Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications

The Danish company Novo says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.

Related

More Finance

FinanceOriginal

It’s getting easier for terminally ill people to end their own lives. What to know as laws change.

Anchor News-1d ago

FinanceOriginal

Your healthcare could now cost $185,500 in retirement — and that doesn’t include long-term care

Anchor News-1d ago

FinanceOriginal

Alphabet is pouring record cash into data centers, and earnings will show whether that’s paying off

Anchor News-1d ago

FinanceOriginal

Novo Nordisk sues Eli Lilly over ‘deliberately false’ weight-loss drug ads

Anchor News-1d ago